04128nam a22005775i 4500 978-981-97-7568-2 DE-He213 20251030113314.0 cr nn 008mamaa 241115s2024 si | s |||| 0|eng d 9789819775682 978-981-97-7568-2 10.1007/978-981-97-7568-2 doi RM300-666 MMG bicssc MED071000 bisacsh MKG thema Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors in Heart Failure [electronic resource] : Mechanisms and Clinical Applications: A Machine-Generated Literature Overview / edited by Mukesh Nandave. 1st ed. 2024. Singapore : Springer Nature Singapore : Imprint: Springer, 2024. XIV, 528 p. 10 illus., 9 illus. in color. online resource. text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Chapter 1_ The History of the Development of Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors for the Treatment of Diabetes: from biology to Chemistry -- Chapter 2_ Sodium-glucose Cotransporter-2 (SGLT2) inhibitors and mechanism of cardiovascular benefits in type 2 diabetes -- Chapter 3_ Sodium-glucose Cotransporter-2 (SGLT2) inhibitors for primary and secondary protection from cardiovascular and renal diseases in Type 2 diabetes -- Chapter 4_ Sodium-glucose Cotransporter-2 (SGLT2) inhibitors: Emerging opportunities for the treatment of myocardial infarction -- Chapter 5_ Potential Role of Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment and Prevention of Diabetic Cardiomyopathy -- Chapter 6_ Contemporary Management, unmet needs, and Therapeutic Potential of Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors in congestive heart failure -- Chapter 7 A comprehensive review of preclinical and clinical information on the cardiovascular advantages of Sodium-glucose Cotransporter-2 (SGLT2) inhibitors -- Chapter 8_ Exploring the current selective drugs of Sodium-glucose Cotransporter-2 (SGLT2) inhibitors for the treatment of cardiovascular disease in Type 2 Diabetes -- Chapter 9_ A comprehensive review of Sodium-glucose Cotransporter-2 (SGLT2) inhibitor’s effects on cardiovascular events, mortality, and significant safety outcomes in individuals with type 2 diabetes. The auto-summaries have been generated by a recursive clustering algorithm via the Dimensions Auto-summarizer by Digital Science handled by Subject Matter Experts and the editor(s) of this book. The editor(s) of this book selected which SN content should be auto-summarized and decided its order of appearance. Please be aware that these are extractive auto-summaries, which consist of original sentences, but are not representative of its original paper, since we do not show the full length of the publication. Please note that only published SN content is represented here, and that machine-generated books are still at an experimental stage. Pharmacology. 67844 Medicine Research. 62598 Biology Research. 65629 Pharmacovigilance. 74275 Medicine. 63923 Cardiology. 75410 Pharmacology. 67844 Biomedical Research. 65633 Drug Safety and Pharmacovigilance. 74276 Clinical Medicine. Cardiology. 75410 Nandave, Mukesh. editor. edt http://id.loc.gov/vocabulary/relators/edt 74724 SpringerLink (Online service) Springer Nature eBook Printed edition: 9789819775675 Printed edition: 9789819775699 Printed edition: 9789819775705 https://doi.org/10.1007/978-981-97-7568-2 ZDB-2-SME ZDB-2-SXM 64975 64975